Hill-Rom Holdings Inc (HRC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | HRC | SNN | BIO | ||
Company | Hill-Rom Holdings Inc | Smith & Nephew Snats ADR | Bio-Rad Laboratories | ||
Price Information | |||||
Exchange | NYSE | NYSE | NYSE | ||
Open | 155.89 | 24.46 | 274.20 | ||
High | 155.99 | 24.58 | 274.74 | ||
Low | 155.85 | 24.07 | 269.05 | ||
Last | 155.96 | 24.13 | 269.75 | ||
Change | +0.05 | -0.48 | -7.36 | ||
% Change | +0.03% | -1.95% | -2.66% | ||
Volume | 566,400 | 1,173,500 | 307,200 | ||
20-Day Average Volume | 591,505 | 1,009,770 | 207,825 | ||
Previous Close | 155.91 | 24.61 | 277.11 | ||
Industry | Medical Products | Medical Products | Medical Products | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 155.64 | 24.26 | 298.58 | ||
20-Day Raw Stochastic | 77.97% | 41.03% | 1.17% | ||
20-Day Relative Strength | 69.62% | 41.74% | 29.48% | ||
Weighted Alpha | +56.56 | -23.70 | -33.17 | ||
Today's Opinion | 100% Buy | 72% Sell | 72% Sell | ||
Previous Opinion | 100% Buy | 56% Sell | 72% Sell | ||
Last Month's Opinion | 100% Buy | 56% Sell | 24% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.18% since 12/03/21 | -2.70% since 04/23/24 | -5.44% since 04/23/24 | ||
Low | 155.66 on 12/06/21 | 23.86 on 04/25/24 | 269.05 on 04/30/24 | ||
High | 156.05 on 12/08/21 | 24.75 on 04/29/24 | 285.27 on 04/24/24 | ||
1-Month | |||||
%Chg | +0.55% since 11/10/21 | -4.85% since 03/28/24 | -22.01% since 03/28/24 | ||
Low | 155.04 on 11/12/21 | 23.65 on 04/16/24 | 268.92 on 04/18/24 | ||
High | 156.22 on 11/17/21 | 24.86 on 04/01/24 | 346.83 on 04/01/24 | ||
3-Month | |||||
%Chg | +3.37% since 09/10/21 | -13.20% since 01/30/24 | -18.85% since 01/30/24 | ||
Low | 149.20 on 09/28/21 | 23.65 on 04/16/24 | 268.92 on 04/18/24 | ||
High | 156.22 on 11/17/21 | 28.93 on 02/22/24 | 364.24 on 02/16/24 | ||
6-Month | |||||
%Chg | +36.87% since 06/10/21 | +9.73% since 10/30/23 | +0.14% since 10/30/23 | ||
Low | 110.96 on 06/22/21 | 21.97 on 11/01/23 | 267.86 on 11/01/23 | ||
High | 156.22 on 11/17/21 | 28.93 on 02/22/24 | 364.24 on 02/16/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 10,301,159 | 10,548,839 | 7,692,728 | ||
Shares Outstanding, K | 66,050 | 437,167 | 28,518 | ||
Annual Sales | 3,018,700,000 | 5,549,000,000 | 2,671,260,000 | ||
Annual Net Income | 248,500,000 | 263,000,000 | -637,320,000 | ||
Last Quarter Sales | 797,900,000 | 1,249,000,000 | 681,180,000 | ||
Last Quarter Net Income | 53,400,000 | 160,000,000 | 349,710,000 | ||
60-Month Beta | 0.55 | 0.73 | 0.87 | ||
Per-Share Information | |||||
Most Recent Earnings | 1.67 on 11/05/21 | N/A | 3.10 on 02/15/24 | ||
Latest Earnings Date | 02/04/22 | 02/27/24 | 05/07/24 | ||
Most Recent Dividend | 0.240 on 12/14/21 | 0.452 on 04/01/24 | N/A | ||
Next Ex-Dividends Date | 12/14/21 | 04/01/24 | N/A | ||
Ratios | |||||
Price/Earnings ttm | 24.71 | 0.00 | 23.54 |